Literature DB >> 21450450

How many HIV infections are prevented by Vancouver Canada's supervised injection facility?

Steven D Pinkerton1.   

Abstract

Mathematical modelling analyses of drug injection-related HIV risk reduction interventions can provide policy makers, researchers, and others with important information that would be difficult to obtain through other means. The validity of the results of mathematical modelling analyses that rely on secondary data sources critically depends on the model(s) employed in the analyses and the parameter values used to populate the models. A recent article in the International Journal of Drug Policy by Andresen and Boyd (2010: 70-76) utilised four different mathematical models of injection-related HIV transmission to estimate the number of HIV infections prevented by Vancouver Canada's Insite supervised injection facility (SIF). The present article reviews and critiques the mathematical models utilised in the Andresen and Boyd article, then describes an alternative-and potentially more accurate-method for estimating the impact of the Insite SIF. This model indicates that the SIF prevents approximately 5-6 infections per year, with a plausible range of 4-8 prevented infections. These estimates are far smaller than suggested by Andresen and Boyd (19-57 prevented infections).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21450450     DOI: 10.1016/j.drugpo.2011.03.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  20 in total

1.  Reducing the adverse impact of injection drug use in Canada.

Authors:  Kevin B Laupland; John M Embil
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Does evidence support supervised injection sites?

Authors:  Jennifer Ng; Christy Sutherland; Michael R Kolber
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

Review 3.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

4.  Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.

Authors:  Alexis M Roth; Alex H Kral; Allison Mitchell; Rohit Mukherjee; Peter Davidson; Stephen E Lankenau
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

5.  Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.

Authors:  Nadia Fairbairn; Evan Wood
Journal:  Addiction       Date:  2016-03       Impact factor: 6.526

6.  Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.

Authors:  Ehsan Jozaghi; Asheka Jackson
Journal:  Int J Health Policy Manag       Date:  2015-03-29

7.  Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia.

Authors:  Anneli Uusküla; Don C Des Jarlais; Mait Raag; Steven D Pinkerton; Jonathan Feelemyer
Journal:  AIDS Care       Date:  2014-07-23

Review 8.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

Review 9.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

10.  30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs.

Authors:  D C Des Jarlais; S Pinkerton; H Hagan; V Guardino; J Feelemyer; H Cooper; A Hatzatkis; A Uuskula
Journal:  Adv Prev Med       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.